Top 10 Cellular Analysis Market by Technology (Imaging, PCR, Flow Cytometry, High-content Screening, Blotting, Spectrophotometry), Application (Stem Cell, Cancer, Tissue Engineering) & End User (Biotechnology, Research) - Global Forecast to 2021
The top 10 cellular analysis market is expected to reach USD 41.34 billion by 2021 from USD 28.66 billion in 2016, at a CAGR of 7.6% during the forecast period. Factors such as increasing government support in the form of funding in cell biology-based research, growing biotechnology industry, increasing prevalence of chronic and infectious diseases, and rising number of cancer cases are driving the growth of the top 10 cellular analysis market.
The top 10 cellular analysis market is categorized based on technology, application, end user, and region. The technology segments include cell imaging techniques, cell counting, flow cytometry, polymerase chain reaction (PCR), spectrophotometry, blotting, sample preparation technologies, high-content screening, centrifugation, and cell microarray technology. The cell imaging techniques segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. Factors such as the rising incidence of diseases such as cancer, growing investments in cell biology research, and new product launches are driving the growth of this market.
On the basis of application, the top 10 cellular analysis market is categorized into biopharmaceutical applications, cancer research, stem cell research, tissue engineering and regenerative medicine, and other applications (virology, organ cultures, IVF, in vitro diagnostics, and genetic counselling). In 2016, the biopharmaceutical applications segment is expected to account for the largest share of the top 10 cellular analysis market. The increasing adoption of cell analysis technologies for the isolation of biomolecules is the key factor driving the growth of this application segment.
The end-user segments of the top 10 cellular analysis market include hospitals and diagnostic laboratories, biotechnology and pharmaceutical companies, research laboratories and institutes, cell banks, and other end users (blood banks, food and beverage manufacturers, environmental monitoring organizations, and forensic laboratories). The hospitals and diagnostic laboratories segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. Factors such as increasing investments in healthcare systems and high prevalence of infectious and chronic diseases are driving the growth of the hospitals and diagnostic laboratories segment.
Geographically, the top 10 cellular analysis market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The large share of the North American market can be attributed to increasing government support for cancer and stem cell research as well as the growth of the biotechnology and biopharmaceutical industries in the region.
The major players in the top 10 cellular analysis market are Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), Beckman Coulter, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Olympus Corporation (Japan), GE Healthcare (U.S.), Tecan Group (Switzerland), and Nikon Instruments (Japan).
Research Coverage:
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the top 10 cellular analysis market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
The top 10 cellular analysis market is categorized based on technology, application, end user, and region. The technology segments include cell imaging techniques, cell counting, flow cytometry, polymerase chain reaction (PCR), spectrophotometry, blotting, sample preparation technologies, high-content screening, centrifugation, and cell microarray technology. The cell imaging techniques segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. Factors such as the rising incidence of diseases such as cancer, growing investments in cell biology research, and new product launches are driving the growth of this market.
On the basis of application, the top 10 cellular analysis market is categorized into biopharmaceutical applications, cancer research, stem cell research, tissue engineering and regenerative medicine, and other applications (virology, organ cultures, IVF, in vitro diagnostics, and genetic counselling). In 2016, the biopharmaceutical applications segment is expected to account for the largest share of the top 10 cellular analysis market. The increasing adoption of cell analysis technologies for the isolation of biomolecules is the key factor driving the growth of this application segment.
The end-user segments of the top 10 cellular analysis market include hospitals and diagnostic laboratories, biotechnology and pharmaceutical companies, research laboratories and institutes, cell banks, and other end users (blood banks, food and beverage manufacturers, environmental monitoring organizations, and forensic laboratories). The hospitals and diagnostic laboratories segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. Factors such as increasing investments in healthcare systems and high prevalence of infectious and chronic diseases are driving the growth of the hospitals and diagnostic laboratories segment.
Geographically, the top 10 cellular analysis market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The large share of the North American market can be attributed to increasing government support for cancer and stem cell research as well as the growth of the biotechnology and biopharmaceutical industries in the region.
The major players in the top 10 cellular analysis market are Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), Beckman Coulter, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Olympus Corporation (Japan), GE Healthcare (U.S.), Tecan Group (Switzerland), and Nikon Instruments (Japan).
Research Coverage:
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the top 10 cellular analysis market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the top 10 cellular analysis market. The report analyses the top 10 cellular analysis market, by technology, application, end user, and region
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the top 10 cellular analysis market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the top 10 cellular analysis market
- Market Development: Comprehensive information about emerging markets. This report analyses the top 10 cellular analysis market across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the top 10 cellular analysis market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.4 MARKETS COVERED
1.5 YEARS CONSIDERED FOR THE STUDY
1.6 CURRENCY
1.7 LIMITATIONS
1.8 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 TOP 10 CELLULAR ANALYSIS: MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: TOP 10 CELLULAR ANALYSIS MARKET, BY TECHNOLOGY
4.3 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2016 VS. 2021
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Availability of funding for cell-based research
5.2.1.2 Rising incidence of chronic and infectious diseases
5.2.1.3 Increasing number of patients suffering from cancer
5.2.1.4 Technological advancements in cell analysis instruments
5.2.1.5 Growing biotechnology and biopharmaceutical industries
5.2.2 RESTRAINTS
5.2.2.1 High cost of cell analysis systems
5.2.2.2 Ethical issues related to embryonic stem cell research
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging Markets
5.2.3.2 Growing stem cell research
5.2.3.3 Emergence of microfluidics
5.2.4 CHALLENGE
5.2.4.1 Complexities related to reagent development
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INTEGRATION OF BASIC FLOW CYTOMETRY TECHNIQUES IN MODERN HEMATOLOGY ANALYZERS
6.2.2 ACQUISITION OF SMALL PLAYERS
6.3 VALUE CHAIN ANALYSIS
6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 THREAT OF NEW ENTRANTS
6.4.2 BARGAINING POWER OF SUPPLIERS
6.4.3 BARGAINING POWER OF BUYERS
6.4.4 INTENSITY OF COMPETITIVE RIVALRY
6.4.5 THREAT OF SUBSTITUTES
7 GLOBAL TOP 10 CELLULAR ANALYSIS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 CELL IMAGING TECHNOLOGIES
7.3 FLOW CYTOMETRY
7.4 SPECTROPHOTOMETRY
7.5 PCR (POLYMERASE CHAIN REACTION)
7.6 CELL COUNTING
7.7 BLOTTING
7.8 HIGH-CONTENT SCREENING
7.9 SAMPLE PREPARATION TECHNOLOGIES
7.10 CELL MICROARRAY TECHNOLOGY
7.11 CENTRIFUGATION
8 TOP 10 CELLULAR ANALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 BIOPHARMACEUTICAL APPLICATIONS
8.3 STEM CELL RESEARCH
8.4 CANCER RESEARCH
8.5 TISSUE ENGINEERING & REGENERATIVE MEDICINE
8.6 OTHER APPLICATIONS
9 TOP 10 CELLULAR ANALYSIS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS AND DIAGNOSTIC LABORATORIES
9.3 RESEARCH LABORATORIES AND INSTITUTES
9.4 CELL BANKS
9.5 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
9.6 OTHER END USERS
10 GLOBAL TOP 10 CELLULAR ANALYSIS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA
10.5 ROW
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 LEADING PLAYERS IN THE TOP 10 CELLULAR ANALYSIS MARKET
11.3 COMPETITIVE SITUATIONS AND TRENDS
11.3.1 PRODUCT LAUNCHES
11.3.2 AGREEMENTS
11.3.3 ACQUISITIONS
11.3.4 EXPANSIONS
12 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION
12.2 THERMO FISHER SCIENTIFIC, INC.
12.3 BECKMAN COULTER INC. (A SUBSIDIARY OF DANAHER CORPORATION)
12.4 MERCK KGAA
12.5 BIO-RAD LABORATORIES, INC.
12.6 BECTON, DICKINSON AND COMPANY
12.7 AGILENT TECHNOLOGIES, INC.
12.8 GE HEALTHCARE
12.9 OLYMPUS CORPORATION
12.10 TECAN GROUP LTD.
12.11 NIKON CORPORATION
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INDUSTRY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.4 MARKETS COVERED
1.5 YEARS CONSIDERED FOR THE STUDY
1.6 CURRENCY
1.7 LIMITATIONS
1.8 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 TOP 10 CELLULAR ANALYSIS: MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: TOP 10 CELLULAR ANALYSIS MARKET, BY TECHNOLOGY
4.3 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2016 VS. 2021
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Availability of funding for cell-based research
5.2.1.2 Rising incidence of chronic and infectious diseases
5.2.1.3 Increasing number of patients suffering from cancer
5.2.1.4 Technological advancements in cell analysis instruments
5.2.1.5 Growing biotechnology and biopharmaceutical industries
5.2.2 RESTRAINTS
5.2.2.1 High cost of cell analysis systems
5.2.2.2 Ethical issues related to embryonic stem cell research
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging Markets
5.2.3.2 Growing stem cell research
5.2.3.3 Emergence of microfluidics
5.2.4 CHALLENGE
5.2.4.1 Complexities related to reagent development
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INTEGRATION OF BASIC FLOW CYTOMETRY TECHNIQUES IN MODERN HEMATOLOGY ANALYZERS
6.2.2 ACQUISITION OF SMALL PLAYERS
6.3 VALUE CHAIN ANALYSIS
6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 THREAT OF NEW ENTRANTS
6.4.2 BARGAINING POWER OF SUPPLIERS
6.4.3 BARGAINING POWER OF BUYERS
6.4.4 INTENSITY OF COMPETITIVE RIVALRY
6.4.5 THREAT OF SUBSTITUTES
7 GLOBAL TOP 10 CELLULAR ANALYSIS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 CELL IMAGING TECHNOLOGIES
7.3 FLOW CYTOMETRY
7.4 SPECTROPHOTOMETRY
7.5 PCR (POLYMERASE CHAIN REACTION)
7.6 CELL COUNTING
7.7 BLOTTING
7.8 HIGH-CONTENT SCREENING
7.9 SAMPLE PREPARATION TECHNOLOGIES
7.10 CELL MICROARRAY TECHNOLOGY
7.11 CENTRIFUGATION
8 TOP 10 CELLULAR ANALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 BIOPHARMACEUTICAL APPLICATIONS
8.3 STEM CELL RESEARCH
8.4 CANCER RESEARCH
8.5 TISSUE ENGINEERING & REGENERATIVE MEDICINE
8.6 OTHER APPLICATIONS
9 TOP 10 CELLULAR ANALYSIS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS AND DIAGNOSTIC LABORATORIES
9.3 RESEARCH LABORATORIES AND INSTITUTES
9.4 CELL BANKS
9.5 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
9.6 OTHER END USERS
10 GLOBAL TOP 10 CELLULAR ANALYSIS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA
10.5 ROW
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 LEADING PLAYERS IN THE TOP 10 CELLULAR ANALYSIS MARKET
11.3 COMPETITIVE SITUATIONS AND TRENDS
11.3.1 PRODUCT LAUNCHES
11.3.2 AGREEMENTS
11.3.3 ACQUISITIONS
11.3.4 EXPANSIONS
12 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION
12.2 THERMO FISHER SCIENTIFIC, INC.
12.3 BECKMAN COULTER INC. (A SUBSIDIARY OF DANAHER CORPORATION)
12.4 MERCK KGAA
12.5 BIO-RAD LABORATORIES, INC.
12.6 BECTON, DICKINSON AND COMPANY
12.7 AGILENT TECHNOLOGIES, INC.
12.8 GE HEALTHCARE
12.9 OLYMPUS CORPORATION
12.10 TECAN GROUP LTD.
12.11 NIKON CORPORATION
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INDUSTRY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 TOP 10 CELLULAR ANALYSIS MARKET SNAPSHOT
Table 2 INCIDENCE OF INFECTIOUS DISEASES (HEPATITIS C & CHOLERA)
Table 3 GLOBAL NUMBER OF PATIENTS SUFFERING FROM CANCER, 2015–2030
Table 4 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
Table 5 CELL IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 6 FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 7 SPECTROPHOTOMETRY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 8 PCR MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 9 CELL COUNTING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 10 BLOTTING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 11 HIGH-CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 12 SAMPLE PREPARATION TECHNOLOGIESMARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 13 CELL MICROARRAY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 14 CENTRIFUGATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 15 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 16 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR BIOPHARMACEUTICAL APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 17 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR STEM CELL RESEARCH, BY COUNTRY, 2014–2021 (USD MILLION)
Table 18 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR CANCER RESEARCH, BY COUNTRY, 2014–2021 (USD MILLION)
Table 19 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 20 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 21 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 22 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION)
Table 23 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR RESEARCH LABORATORIES AND INSTITUTES, BY COUNTRY, 2014–2021 (USD MILLION)
Table 24 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR CELL BANKS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 25 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014–2021 (USD MILLION)
Table 26 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 27 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 NORTH AMERICA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 29 NORTH AMERICA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 30 NORTH AMERICA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 31 NORTH AMERICA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 32 U.S.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 33 U.S.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 34 U.S.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 35 CANADA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 36 CANADA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 37 CANADA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 38 EUROPE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 39 EUROPE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 40 EUROPE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 41 EUROPE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 42 GERMANY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 43 GERMANY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 44 GERMANY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 45 FRANCE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 46 FRANCE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 47 FRANCE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 48 U.K.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 49 U.K.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 50 U.K.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 51 ITALY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 52 ITALY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 53 ITALY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 54 SPAIN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 55 SPAIN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 56 SPAIN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 57 ROE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 58 ROE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 59 ROE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 60 ASIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 61 ASIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 62 ASIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 63 ASIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 64 JAPAN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 65 JAPAN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 66 JAPAN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 67 CHINA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 68 CHINA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 69 CHINA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 70 INDIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 71 INDIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 72 INDIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 73 ROA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 74 ROA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 75 ROA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 76 ROW: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 77 ROW: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 78 ROW: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 79 RANK OF COMPANIES IN THE TOP 10 CELLULAR ANALYSIS MARKET
Table 80 PRODUCT LAUNCHES, 2014-2016
Table 81 AGREEMENTS, 2014–2016
Table 82 ACQUISITIONS, 2014–2016
Table 83 EXPANSIONS, 2014–2016
Table 1 TOP 10 CELLULAR ANALYSIS MARKET SNAPSHOT
Table 2 INCIDENCE OF INFECTIOUS DISEASES (HEPATITIS C & CHOLERA)
Table 3 GLOBAL NUMBER OF PATIENTS SUFFERING FROM CANCER, 2015–2030
Table 4 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
Table 5 CELL IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 6 FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 7 SPECTROPHOTOMETRY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 8 PCR MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 9 CELL COUNTING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 10 BLOTTING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 11 HIGH-CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 12 SAMPLE PREPARATION TECHNOLOGIESMARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 13 CELL MICROARRAY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 14 CENTRIFUGATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 15 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 16 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR BIOPHARMACEUTICAL APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 17 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR STEM CELL RESEARCH, BY COUNTRY, 2014–2021 (USD MILLION)
Table 18 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR CANCER RESEARCH, BY COUNTRY, 2014–2021 (USD MILLION)
Table 19 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 20 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 21 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 22 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION)
Table 23 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR RESEARCH LABORATORIES AND INSTITUTES, BY COUNTRY, 2014–2021 (USD MILLION)
Table 24 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR CELL BANKS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 25 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014–2021 (USD MILLION)
Table 26 TOP 10 CELLULAR ANALYSIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 27 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 NORTH AMERICA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 29 NORTH AMERICA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 30 NORTH AMERICA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 31 NORTH AMERICA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 32 U.S.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 33 U.S.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 34 U.S.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 35 CANADA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 36 CANADA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 37 CANADA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 38 EUROPE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 39 EUROPE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 40 EUROPE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 41 EUROPE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 42 GERMANY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 43 GERMANY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 44 GERMANY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 45 FRANCE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 46 FRANCE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 47 FRANCE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 48 U.K.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 49 U.K.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 50 U.K.: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 51 ITALY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 52 ITALY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 53 ITALY: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 54 SPAIN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 55 SPAIN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 56 SPAIN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 57 ROE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 58 ROE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 59 ROE: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 60 ASIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 61 ASIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 62 ASIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 63 ASIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 64 JAPAN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 65 JAPAN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 66 JAPAN: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 67 CHINA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 68 CHINA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 69 CHINA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 70 INDIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 71 INDIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 72 INDIA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 73 ROA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 74 ROA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 75 ROA: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 76 ROW: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 77 ROW: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 78 ROW: TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 79 RANK OF COMPANIES IN THE TOP 10 CELLULAR ANALYSIS MARKET
Table 80 PRODUCT LAUNCHES, 2014-2016
Table 81 AGREEMENTS, 2014–2016
Table 82 ACQUISITIONS, 2014–2016
Table 83 EXPANSIONS, 2014–2016
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 TOP 10 CELLULAR ANALYSIS MARKET: BOTTOM-UP APPROACH
Figure 3 TOP-DOWN APPROACH
Figure 4 DATA TRIANGULATION METHODOLOGY
Figure 5 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD BILLION)
Figure 6 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD BILLION)
Figure 7 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD BILLION)
Figure 8 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY REGION, 2016 VS. 2021 (USD BILLION)
Figure 9 TOP 10 CELLULAR ANALYSIS MARKET
Figure 10 CELL IMAGING TECHNIQUES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
Figure 11 BIOPHARMACEUTICAL APPLICATIONS TO REGISTER THE HIGHEST CAGR FROM 2016 TO 2021
Figure 12 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 13 TOP 10 CELLULAR ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 14 NIH FUNDING IN THE U.S., 2013 VS. 2016 (USD MILLION)
Figure 15 DIABETES CASES, 2015 VS. 2040 (MILLION)
Figure 16 GLOBAL HIV PREVALENCE (ALL AGES), 2010 VS. 2015 (MILLION)
Figure 17 VALUE CHAIN ANALYSIS
Figure 18 SIGNIFICANT GROWTH POTENTIAL IN THE TOP 10 CELLULAR ANALYSIS MARKET IS ENHANCING COMPETITION AMONG MARKET PLAYERS
Figure 19 CELL IMAGING TECHNIQUES SEGMENT TO DOMINATE THE MARKET IN 2016–2021
Figure 20 BIOPHARMACEUTICAL APPLICATIONS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2016
Figure 21 HOSPITALS AND DIAGNOSTIC LABORATORIES SEGMENT TO COMMAND THE LARGEST SHARE OF THE MARKET IN 2016
Figure 22 ASIAN TOP 10 CELLULAR ANALYSIS MARKET EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 23 NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 24 NORTH AMERICA: MARKET SNAPSHOT
Figure 25 U.S.: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 26 CELL IMAGINE TECHNIQUES TO ACCOUNT FOR THE LARGEST SHARE IN THE U.S. TOP 10 CELLULAR ANALYSIS MARKET IN 2016
Figure 27 CANADA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 28 EUROPE: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 29 EUROPE: MARKET SNAPSHOT
Figure 30 GERMANY: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 31 PCR SEGMENT TO REGISTER THE HIGHEST CAGR IN THE GERMAN TOP 10 CELLULAR ANALYSIS MARKET FROM 2016 TO 2021
Figure 32 FRANCE: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 33 U.K.: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 34 ITALY: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 35 SPAIN: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 36 ASIA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 37 ASIA: MARKET SNAPSHOT
Figure 38 JAPAN: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 39 THE BIOPHARMACEUTICAL APPLICATIONS SEGMENT TO HOLD THE LARGEST SHARE IN THE JAPANESE MARKET
Figure 40 CHINA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 41 INDIA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 42 ROW: MARKET SNAPSHOT
Figure 43 PRODUCT LAUNCHES, THE KEY STRATEGY ADOPTED BY LEADING PLAYERS
Figure 44 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & AGREEMENTS, THE KEY GROWTH STRATEGIES ADOPTED BETWEEN 2014 & 2016
Figure 45 PRODUCT BENCHMARKING OF THE TOP 5 PLAYERS
Figure 46 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
Figure 47 DANAHER CORPORATION: COMPANY SNAPSHOT
Figure 48 MERCK KGAA: COMPANY SNAPSHOT
Figure 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
Figure 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
Figure 52 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
Figure 53 OLYMPUS CORPORATION: COMPANY SNAPSHOT
Figure 54 TECAN GROUP LTD: COMPANY SNAPSHOT
Figure 55 NIKON CORPORATION: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN
Figure 2 TOP 10 CELLULAR ANALYSIS MARKET: BOTTOM-UP APPROACH
Figure 3 TOP-DOWN APPROACH
Figure 4 DATA TRIANGULATION METHODOLOGY
Figure 5 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD BILLION)
Figure 6 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD BILLION)
Figure 7 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD BILLION)
Figure 8 TOP 10 CELLULAR ANALYSIS MARKET SIZE, BY REGION, 2016 VS. 2021 (USD BILLION)
Figure 9 TOP 10 CELLULAR ANALYSIS MARKET
Figure 10 CELL IMAGING TECHNIQUES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
Figure 11 BIOPHARMACEUTICAL APPLICATIONS TO REGISTER THE HIGHEST CAGR FROM 2016 TO 2021
Figure 12 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 13 TOP 10 CELLULAR ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 14 NIH FUNDING IN THE U.S., 2013 VS. 2016 (USD MILLION)
Figure 15 DIABETES CASES, 2015 VS. 2040 (MILLION)
Figure 16 GLOBAL HIV PREVALENCE (ALL AGES), 2010 VS. 2015 (MILLION)
Figure 17 VALUE CHAIN ANALYSIS
Figure 18 SIGNIFICANT GROWTH POTENTIAL IN THE TOP 10 CELLULAR ANALYSIS MARKET IS ENHANCING COMPETITION AMONG MARKET PLAYERS
Figure 19 CELL IMAGING TECHNIQUES SEGMENT TO DOMINATE THE MARKET IN 2016–2021
Figure 20 BIOPHARMACEUTICAL APPLICATIONS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2016
Figure 21 HOSPITALS AND DIAGNOSTIC LABORATORIES SEGMENT TO COMMAND THE LARGEST SHARE OF THE MARKET IN 2016
Figure 22 ASIAN TOP 10 CELLULAR ANALYSIS MARKET EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 23 NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 24 NORTH AMERICA: MARKET SNAPSHOT
Figure 25 U.S.: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 26 CELL IMAGINE TECHNIQUES TO ACCOUNT FOR THE LARGEST SHARE IN THE U.S. TOP 10 CELLULAR ANALYSIS MARKET IN 2016
Figure 27 CANADA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 28 EUROPE: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 29 EUROPE: MARKET SNAPSHOT
Figure 30 GERMANY: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 31 PCR SEGMENT TO REGISTER THE HIGHEST CAGR IN THE GERMAN TOP 10 CELLULAR ANALYSIS MARKET FROM 2016 TO 2021
Figure 32 FRANCE: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 33 U.K.: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 34 ITALY: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 35 SPAIN: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 36 ASIA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 37 ASIA: MARKET SNAPSHOT
Figure 38 JAPAN: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 39 THE BIOPHARMACEUTICAL APPLICATIONS SEGMENT TO HOLD THE LARGEST SHARE IN THE JAPANESE MARKET
Figure 40 CHINA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 41 INDIA: CANCER INCIDENCE & MORTALITY, 2012–2035
Figure 42 ROW: MARKET SNAPSHOT
Figure 43 PRODUCT LAUNCHES, THE KEY STRATEGY ADOPTED BY LEADING PLAYERS
Figure 44 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & AGREEMENTS, THE KEY GROWTH STRATEGIES ADOPTED BETWEEN 2014 & 2016
Figure 45 PRODUCT BENCHMARKING OF THE TOP 5 PLAYERS
Figure 46 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
Figure 47 DANAHER CORPORATION: COMPANY SNAPSHOT
Figure 48 MERCK KGAA: COMPANY SNAPSHOT
Figure 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
Figure 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
Figure 52 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
Figure 53 OLYMPUS CORPORATION: COMPANY SNAPSHOT
Figure 54 TECAN GROUP LTD: COMPANY SNAPSHOT
Figure 55 NIKON CORPORATION: COMPANY SNAPSHOT
